Clinical Trial Update: Clinical Trial to Evaluate the Effects of Letermovir Prophylaxis on T-cell Immune Activation in Participants With Treated HIV-1 Infection [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluates whether letermovir prophylaxis affects T-cell immune activation in participants with treated HIV-1 infection; the study status is N…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Letermovir (letermovir)

Snippet

Sponsor: University College, London | Conditions: HIV | Phase 2 | Status: NOT_YET_RECRUITING